Search Results 2291-2300 of 20202 for Receptor

1. A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy - Mayo Clinic

   ... receptor kinase (NTRK ) inhibitor, in regions where these therapies are available and deemed appropriate by the investigator. -Prior HGG treatment ...

2. Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations - Mayo Clinic

   ... receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma multiforme (GBM) expressing EGFR ...

3. Virology and Gene Therapy - Tracks - Ph.D. Program in Biomedical Science

   “The Role of a Chemokine Receptor CCR8 in Regulation of Type 2 Immunity in Response to Airborne Allergens” Min-Jhen Jheng (Mentor: Hirohito Kita, M.D.) ...

4. Publications - Gabor Bagameri, M.D., M.S. - Mayo Clinic

   Distribution and localization of angiotensin II receptor subtypes AT1 and AT2 in the rat liver. Zeitschrift für Gastroenterologie.2001;39:(5):381. Feher E ...

5. Neurosurgery - Clinical trials

   Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

6. Dacomitinib (oral route) - Side effects & dosage - Mayo Clinic

   Dacomitinib is used to treat non-small cell lung cancer that has spread (metastatic) with an epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 ...

7. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

   Prior exposure to ibrutinib or to a B-cell receptor (BCR) inhibitor (e.g., Bruton tyrosine kinase [Btk] inhibitors or phosphoinositide-3 [PI3] kinase ...

8. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   Recurrent Metastatic Breast Cancer: Human Epidermal Growth Factor Receptor 2 - negative (HER2(-)) recurrent metastatic Breast Cancer: Subject has a ...

9. Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer - Mayo Clinic

   Patients may have received targeted agents (angiogenesis inhibitors, epidermal growth factor receptor [EGFR] inhibitors, mammalian target of rapamycin [mTOR] ...

10. No specific characteristics associated with poor response to elagolix with add-back therapy in patients with uterine fibroids - Mayo Clinic

    Progesterone receptor modulators have been widely used outside the United States, yet rare but serious problems with liver function have kept them from approval ...